Arabic Arabic English English French French German German
dark

UKLS trial meta-analysis confirms that low dose CT screening for lung cancer reduces mortality

Low-dose CT lung cancer (LDCT) screening is associated with a 16 percent relative reduction in lung cancer mortality, when compared against a non-LDCT control arm, according to research presented by Professor John Field and the United Kingdom Cancer Screening Trial (UKLS) Team today at the IASLC 2021 World Conference on Lung Cancer. The research will be published in The Lancet Regional Health-Europe. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Almost two thirds of thoracic oncologists used telehealth for the first-time during pandemic: IASLC survey

Next Post

Neoadjuvant cisplatin, pemetrexed plus atezolizumab followed by surgical resection, maintenance atezolizumab is safe

Related Posts
Total
0
Share